View in EDS

GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.

Saved in:
Bibliographic Details
Title: GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
Authors: Nuermberger EL; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Martínez-Martínez MS; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Sanz O; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Urones B; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Esquivias J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Soni H; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Tasneen R; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Tyagi S; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Li SY; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Converse PJ; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Boshoff HI; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Robertson GT; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA., Besra GS; Institute of Microbiology and Infection, School of Biosciences, University of Birminghamgrid.6572.6, Birmingham, United Kingdom., Abrahams KA; Institute of Microbiology and Infection, School of Biosciences, University of Birminghamgrid.6572.6, Birmingham, United Kingdom., Upton AM; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA., Mdluli K; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA., Boyle GW; GSK: Research, GlaxoSmithKline R&D, Ware, United Kingdom., Turner S; GSK: Research, GlaxoSmithKline R&D, Ware, United Kingdom., Fotouhi N; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA., Cammack NC; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Siles JM; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Alonso M; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Escribano J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Lelievre J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Rullas-Trincado J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Pérez-Herrán E; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Bates RH; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Maher-Edwards G; GSK, Brentford, Middlesex, United Kingdom., Barros D; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Ballell L; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Jiménez E; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Jun 21; Vol. 66 (6), pp. e0013222. Date of Electronic Publication: 2022 May 24.
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35607978
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nuermberger+EL%22">Nuermberger EL</searchLink>; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Martínez-Martínez+MS%22">Martínez-Martínez MS</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sanz+O%22">Sanz O</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Urones+B%22">Urones B</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Esquivias+J%22">Esquivias J</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Soni+H%22">Soni H</searchLink>; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Tasneen+R%22">Tasneen R</searchLink>; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Tyagi+S%22">Tyagi S</searchLink>; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Li+SY%22">Li SY</searchLink>; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Converse+PJ%22">Converse PJ</searchLink>; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Boshoff+HI%22">Boshoff HI</searchLink>; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Robertson+GT%22">Robertson GT</searchLink>; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Besra+GS%22">Besra GS</searchLink>; Institute of Microbiology and Infection, School of Biosciences, University of Birminghamgrid.6572.6, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Abrahams+KA%22">Abrahams KA</searchLink>; Institute of Microbiology and Infection, School of Biosciences, University of Birminghamgrid.6572.6, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Upton+AM%22">Upton AM</searchLink>; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Mdluli+K%22">Mdluli K</searchLink>; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Boyle+GW%22">Boyle GW</searchLink>; GSK: Research, GlaxoSmithKline R&D, Ware, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Turner+S%22">Turner S</searchLink>; GSK: Research, GlaxoSmithKline R&D, Ware, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fotouhi+N%22">Fotouhi N</searchLink>; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Cammack+NC%22">Cammack NC</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Siles+JM%22">Siles JM</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Alonso+M%22">Alonso M</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Escribano+J%22">Escribano J</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lelievre+J%22">Lelievre J</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rullas-Trincado+J%22">Rullas-Trincado J</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-Herrán+E%22">Pérez-Herrán E</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bates+RH%22">Bates RH</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Maher-Edwards+G%22">Maher-Edwards G</searchLink>; GSK, Brentford, Middlesex, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barros+D%22">Barros D</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ballell+L%22">Ballell L</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Jiménez+E%22">Jiménez E</searchLink>; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220315061%22">Antimicrobial agents and chemotherapy</searchLink> [Antimicrob Agents Chemother] 2022 Jun 21; Vol. 66 (6), pp. e0013222. <i>Date of Electronic Publication: </i>2022 May 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Intramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Microbiology%22">American Society for Microbiology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0315061 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-6596 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200664804%22">00664804 </searchLink><i>NLM ISO Abbreviation: </i>Antimicrob Agents Chemother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35607978
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1128/aac.00132-22
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0013222
    Titles:
      – TitleFull: GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nuermberger EL
      – PersonEntity:
          Name:
            NameFull: Martínez-Martínez MS
      – PersonEntity:
          Name:
            NameFull: Sanz O
      – PersonEntity:
          Name:
            NameFull: Urones B
      – PersonEntity:
          Name:
            NameFull: Esquivias J
      – PersonEntity:
          Name:
            NameFull: Soni H
      – PersonEntity:
          Name:
            NameFull: Tasneen R
      – PersonEntity:
          Name:
            NameFull: Tyagi S
      – PersonEntity:
          Name:
            NameFull: Li SY
      – PersonEntity:
          Name:
            NameFull: Converse PJ
      – PersonEntity:
          Name:
            NameFull: Boshoff HI
      – PersonEntity:
          Name:
            NameFull: Robertson GT
      – PersonEntity:
          Name:
            NameFull: Besra GS
      – PersonEntity:
          Name:
            NameFull: Abrahams KA
      – PersonEntity:
          Name:
            NameFull: Upton AM
      – PersonEntity:
          Name:
            NameFull: Mdluli K
      – PersonEntity:
          Name:
            NameFull: Boyle GW
      – PersonEntity:
          Name:
            NameFull: Turner S
      – PersonEntity:
          Name:
            NameFull: Fotouhi N
      – PersonEntity:
          Name:
            NameFull: Cammack NC
      – PersonEntity:
          Name:
            NameFull: Siles JM
      – PersonEntity:
          Name:
            NameFull: Alonso M
      – PersonEntity:
          Name:
            NameFull: Escribano J
      – PersonEntity:
          Name:
            NameFull: Lelievre J
      – PersonEntity:
          Name:
            NameFull: Rullas-Trincado J
      – PersonEntity:
          Name:
            NameFull: Pérez-Herrán E
      – PersonEntity:
          Name:
            NameFull: Bates RH
      – PersonEntity:
          Name:
            NameFull: Maher-Edwards G
      – PersonEntity:
          Name:
            NameFull: Barros D
      – PersonEntity:
          Name:
            NameFull: Ballell L
      – PersonEntity:
          Name:
            NameFull: Jiménez E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 06
              Text: 2022 Jun 21
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1098-6596
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Antimicrobial agents and chemotherapy
              Type: main
ResultId 1